U.S. COMPANY FILING
AbbVie Inc. — Form 8-K filed 2026-02-26
Filing text preview
AbbVie entered into an underwriting agreement on February 24, 2026, to issue $8.0 billion aggregate principal amount of senior notes across multiple tranches, including floating rate notes due 2028 and fixed-rate notes due through 2066. Net proceeds are expected to be approximately $7.95 billion, used to repay amounts outstanding under its $4.0 billion 364-day delayed draw term loan facility (currently $2.0 billion outstanding) and for general corporate purposes. The offering is expected to close on March 4, 2026.
This preview uses text already stored in ReportGem and does not fetch the document from object storage during SEO generation. Review the internal filing record and the official SEC source before relying on it.
Open filing record